Professional-grade financial intelligence

20M+ securities. Real-time data. Institutional insights.

Subscribe for $2

Trusted by professionals at Goldman Sachs, BlackRock, and JPMorgan

Overview
Profile
AVITA Medical Stock

AVITA Medical Stock RCEL

RCEL
US05380C1027
A2P733

Price

5.69
Today +/-
-0.07
Today %
-1.48 %

AVITA Medical stock price

Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the AVITA Medical stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the AVITA Medical stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the AVITA Medical stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze AVITA Medical's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

AVITA Medical Stock Price History

DateAVITA Medical Price
8/15/20255.69 undefined
8/14/20255.78 undefined
8/13/20255.66 undefined
8/12/20255.72 undefined
8/11/20254.77 undefined
8/8/20254.30 undefined
8/8/20254.27 undefined
8/7/20254.02 undefined
8/6/20255.28 undefined
8/5/20255.28 undefined
8/4/20255.34 undefined
7/31/20255.16 undefined
7/30/20255.30 undefined
7/29/20255.36 undefined
7/28/20255.75 undefined
7/27/20255.80 undefined
7/25/20255.78 undefined
7/24/20255.99 undefined
7/23/20256.13 undefined
7/22/20255.67 undefined
7/21/20255.22 undefined
7/18/20255.28 undefined
7/18/20255.10 undefined
7/17/20255.44 undefined

AVITA Medical Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into AVITA Medical, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by AVITA Medical from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects AVITA Medical’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of AVITA Medical. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into AVITA Medical’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing AVITA Medical’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on AVITA Medical’s growth potential.

AVITA Medical Revenue, EBIT and net profit per share

DateAVITA Medical RevenueAVITA Medical EBITAVITA Medical Net Income
2030e403.04 M undefined0 undefined179.39 M undefined
2029e352.93 M undefined155.07 M undefined146.14 M undefined
2028e283.93 M undefined117.38 M undefined113.96 M undefined
2027e183.78 M undefined1.65 M undefined1.72 M undefined
2026e138.03 M undefined-6.69 M undefined-4.56 M undefined
2025e100.98 M undefined-21.94 M undefined-18.05 M undefined
202464.25 M undefined-56 M undefined-61.85 M undefined
202350.14 M undefined-42.35 M undefined-35.38 M undefined
202234.42 M undefined-27.13 M undefined-26.67 M undefined
202113.96 M undefined-14.34 M undefined-14.43 M undefined
202029.23 M undefined-26.31 M undefined-26.58 M undefined
201914.26 M undefined-42.37 M undefined-42.03 M undefined

AVITA Medical Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M)
NET INCOME (M)
NET INCOME GROWTH (%)
SHARES (M)
DOCUMENTS
2019202020212022202320242025e2026e2027e2028e2029e2030e
142913345064100138183283352403
-107.14-55.17161.5447.0628.0056.2538.0032.6154.6424.3814.49
78.5779.3192.3182.3584.0085.9455.0039.8630.0519.4315.6313.65
112312284255000000
-42-26-14-26-35-61-18-41113146179
--38.10-46.1585.7134.6274.29-70.49-77.78-125.0011,200.0029.2022.60
20.2922.6724.922525.3325.88000000
------------
Details

Keystats

ⓘ

Revenue and Growth

The AVITA Medical Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the AVITA Medical is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETS
CASH BALANCE (M)
RECEIVABLES (M)
OTHER REC. (M)
INVENTORIES (M)
OTHER CURRENT LIAB. (M)
CURRENT ASSETS (M)
TANGIBLE ASSETS (M)
LONG-T. INVEST. (M)
LONG-T. REC. (M)
INTANGIBLE ASSETS (M)
GOODWILL (M)
OTHER NON-CURRENT ASSETS (M)
NON-CURRENT ASSETS (M)
TOTAL ASSETS (M)
LIABILITIES
COMMON STOCK (M)
ADDITIONAL PAID-IN CAPITAL (M)
RETAINED EARNINGS (M)
OTHER EQUITY (M)
UNREAL. GAINS/LOSSES (M)
EQUITY (M)
LIABILITIES (M)
PROVISIONS (M)
OTHER SHORT-TERM LIAB. (M)
SHORT-TERM DEBTS (M)
LONG-TERM DEBT PORTION (M)
SHORT-TERM REC. (M)
LONG-T. LIAB. (M)
DEFERRED TAXES (M)
OTHER LIAB. (M)
LONG-T. LIABILITIES (M)
DEBT (M)
TOTAL CAPITAL (M)
201920202021202220232024
           
73.6110.785.279.389.0636
2.13.53.23.97.890
0.44.40.31.10.050
1.11.62.12.15.67.27
1.11.11.311.422
78.3121.392.187.4104.0245.27
3.72.92.82.14.3214
0019.76.900
000000
0.40.50.40.50.495.57
000000
00.80.91.42.833.55
4.14.223.810.97.6423.12
82.4125.5115.998.3111.6668.39
           
000000
259.2328.9332.5339.8350368
-194.9-221.5-235.9-262.6-298-360
8.18.38.17.5-3.02-3.26
000000
72.4115.7104.784.748.984.74
4.33.12.733.790
3.346.17.28.8711
00.20.40.50.542.51
000000
000000
7.67.39.210.713.213.51
00004042
000000
2.42.52.22.89.5713
2.42.52.22.849.5755
109.811.413.562.7768.51
82.4125.5116.198.2111.7573.25
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of AVITA Medical provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand AVITA Medical's financial health and stability.

Assets

AVITA Medical's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that AVITA Medical must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of AVITA Medical after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into AVITA Medical's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)
DEPRECIATION (M)
DEFERRED TAXES (M)
CHANGES IN WORKING CAPITAL (M)
NON-CASH ITEM (M)
PAID INTEREST (k)
PAID TAXES (M)
NET CASH FLOW FROM OPERATING ACTIVITIES (M)
CAPITAL EXPENDITURES (M)
CASH FLOW FROM INVESTING ACTIVITIES (k)
CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)
INTEREST INCOME AND EXPENSES (M)
NET DEBT CHANGE (M)
NET CHANGE IN EQUITY (M)
CASH FLOW FROM FINANCING ACTIVITIES (M)
CASH FLOW FROM OTHER FINANCING ACTIVITIES ()
TOTAL DIVIDENDS PAID (M)
NET CHANGE IN CASH FLOW (M)
FREE CASH FLOW (M)
SHARE-BASED COMPENSATION (M)
201920202021202120222023
-42-26-26-14-26-35
000000
000000
1-7-74-1-6
34121231511
000001,000
000000
-22-25-25-5-19-38
0-1-100-1
0-1,000-1,000-49,000-19,0001,000
000-49-182
000000
0000038
826969001
7764640040
-5.00-5.00-5.00---
000000
533737-55-373
-23.6-27.07-27.07-5.63-19.54-39.39
000000

AVITA Medical stock margins

The AVITA Medical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of AVITA Medical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for AVITA Medical.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the AVITA Medical's sales revenue. A higher gross margin percentage indicates that the AVITA Medical retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the AVITA Medical's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the AVITA Medical's total revenue generated. When comparing the revenue margin year over year, investors can gauge the AVITA Medical's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the AVITA Medical. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the AVITA Medical's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

AVITA Medical Margin History

AVITA Medical Gross marginAVITA Medical Profit marginAVITA Medical EBIT marginAVITA Medical Profit margin
2030e86.6 %0 %44.51 %
2029e86.6 %43.94 %41.41 %
2028e86.6 %41.34 %40.14 %
2027e86.6 %0.9 %0.93 %
2026e86.6 %-4.85 %-3.31 %
2025e86.6 %-21.72 %-17.88 %
202486.6 %-87.16 %-96.26 %
202384.93 %-84.45 %-70.56 %
202283.56 %-78.82 %-77.48 %
202186.67 %-102.73 %-103.37 %
202080.43 %-90.01 %-90.93 %
201981.35 %-297.12 %-294.74 %

AVITA Medical Stock Sales Revenue, EBIT, Earnings per Share

The AVITA Medical earnings per share therefore indicates how much revenue AVITA Medical has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue AVITA Medical earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates AVITA Medical's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of AVITA Medical’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating AVITA Medical's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

AVITA Medical Revenue, EBIT and net profit per share

DateAVITA Medical Sales per ShareAVITA Medical EBIT per shareAVITA Medical Earnings per Share
2030e15.57 undefined0 undefined6.93 undefined
2029e13.64 undefined0 undefined5.65 undefined
2028e10.97 undefined0 undefined4.4 undefined
2027e7.1 undefined0 undefined0.07 undefined
2026e5.33 undefined0 undefined-0.18 undefined
2025e3.9 undefined0 undefined-0.7 undefined
20242.48 undefined-2.16 undefined-2.39 undefined
20231.98 undefined-1.67 undefined-1.4 undefined
20221.38 undefined-1.09 undefined-1.07 undefined
20210.56 undefined-0.58 undefined-0.58 undefined
20201.29 undefined-1.16 undefined-1.17 undefined
20190.7 undefined-2.09 undefined-2.07 undefined

AVITA Medical business model

AVITA Medical Inc is a company in the field of regenerative medicine that focuses on the development and marketing of innovative therapy products for the treatment of burns, chronic wounds, and skin defects. The company was founded in 1998 and is headquartered in Valencia, California. AVITA Medical Inc began with research in the field of regenerative medicine at the University of Western Australia, where the company developed its patented technology known as ReNovaCell. This technology allows for the extraction and cultivation of cells from a small area of skin to create a solution that contains the patient's own skin tissue on a large scale. AVITA Medical Inc's business model is based on the development and marketing of regenerative therapy products based on ReNovaCell technology. The company focuses on commercializing products that enable fast, safe, and effective treatment of burns, chronic wounds, and skin defects. AVITA Medical Inc operates in two main segments: regenerative medicine and aesthetic medicine. In regenerative medicine, the company offers a wide range of products based on ReNovaCell technology, including ReCell, a unique autologous cell therapy for rapid burn treatment, Kelo-Cote, a silicone gel formulation for scar treatment, and therapy-complementary wound treatments. In aesthetic medicine, the company distributes a variety of products under the brand RestoreSkin, which focuses on improving skin health and aesthetic appearance, including pore refinement, pigment reduction, and wrinkle reduction. AVITA Medical Inc has established itself as a leading provider of regenerative therapy products. The company has a strong presence both in the US and internationally and is actively advocating for the advancement of regenerative medicine. By developing innovative products that enable fast and effective treatment of skin defects, AVITA Medical Inc will continue to be a key player in regenerative medicine in the future. AVITA Medical is one of the most popular companies on Eulerpool.com.

AVITA Medical SWOT Analysis

Strengths

Advanced Technology: AVITA Medical Inc utilizes cutting-edge medical technology in their products and services, providing them with a competitive advantage in the market.

Strong Research and Development: The company invests heavily in R&D, allowing them to continuously innovate and develop new, effective solutions for the medical industry.

Established Market Presence: AVITA Medical Inc has built a solid reputation and established relationships with key stakeholders, including healthcare professionals and institutions.

Strong Financial Position: The company boasts a healthy financial standing, enabling them to fund their operations and pursue growth opportunities.

Weaknesses

Limited Product Portfolio: AVITA Medical Inc currently offers a limited range of products, which may limit their market reach and revenue potential.

Dependence on Regulatory Approvals: The company's success heavily relies on obtaining necessary approvals from regulatory authorities, which can delay product launches and impact profitability.

Relatively Small Customer Base: AVITA Medical Inc primarily caters to a niche market, which may result in limited customer base and slower market expansion.

Opportunities

Growing Demand for Regenerative Medicine: The increasing focus on regenerative medicine presents an opportunity for AVITA Medical Inc to expand their product offerings and capture a larger market share.

Expansion into New Geographical Markets: The company can explore untapped international markets to diversify their customer base and drive revenue growth.

Strategic Partnerships and Collaborations: AVITA Medical Inc can leverage strategic partnerships and collaborations with other industry players to enhance their technological capabilities and market presence.

Threats

Intense Competition: The medical industry is highly competitive, and AVITA Medical Inc faces competition from established players as well as emerging startups.

Evolving Regulatory Landscape: Changes in regulations and compliance requirements can impact AVITA Medical Inc's operations and product development processes.

Technological Advancements: Rapid technological advancements may render AVITA Medical Inc's existing products obsolete or less relevant, requiring continuous innovation to stay competitive.

AVITA Medical Revenue by Region

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

AVITA Medical Revenue by Segment

DateAustraliaAUSTRALIAJapanUnited KingdomUNITED KINGDOMUnited States
2022275,000 USD-729,000 USD160,000 USD-33.26 M USD
2021207,000 USD--70,000 USD-28.96 M USD
2020-292,000 USD--171,000 USD13.8 M USD
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

AVITA Medical Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

AVITA Medical historical P/E ratio, EBIT multiple, and P/S ratio

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

AVITA Medical shares outstanding

The number of shares was AVITA Medical in 2024 — This indicates how many shares 25.883 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue AVITA Medical earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates AVITA Medical's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of AVITA Medical’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating AVITA Medical's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

AVITA Medical stock splits

In AVITA Medical's history, there have been no stock splits.
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for AVITA Medical.

AVITA Medical latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/2025-0.25 -0.38  (-50.2 %)2025 Q2
3/31/2025-0.39 -0.53  (-34.96 %)2025 Q1
12/31/2024-0.44 -0.44  (0.41 %)2024 Q4
9/30/2024-0.45 -0.62  (-39.29 %)2024 Q3
6/30/2024-0.53 -0.6  (-13.55 %)2024 Q2
3/31/2024-0.48 -0.73  (-51.23 %)2024 Q1
12/31/2023-0.38 -0.28  (26.68 %)2023 Q4
9/30/2023-0.45 -0.34  (24.93 %)2023 Q3
6/30/2023-0.33 -0.41  (-23.9 %)2023 Q2
3/31/2023-0.26 -0.37  (-44.53 %)2023 Q1
1
2

Eulerpool ESG Scorecard© for the AVITA Medical stock

Eulerpool World ESG Rating (EESG©)

44/ 100

🌱 Environment

45

👫 Social

64

🏛️ Governance

23

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees50.2
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

AVITA Medical shareholders

%
Name
Stocks
Change
Date
6.65985 % BlackRock Institutional Trust Company, N.A.1,723,776-20,8313/31/2025
5.53964 % The Vanguard Group, Inc.1,433,83110,3923/31/2025
2.39425 % Geode Capital Management, L.L.C.619,70722,1123/31/2025
2.03589 % State Street Global Advisors (US)526,952-8,0193/31/2025
1.69995 % Opaleye Management Inc.440,000440,0003/31/2025
1.33187 % UBS Financial Services, Inc.344,728216,0983/31/2025
0.97422 % Northern Trust Investments, Inc.252,15938,4953/31/2025
0.45293 % Goldman Sachs & Company, Inc.117,232-19,7483/31/2025
0.44080 % Marshall Wace LLP114,092114,0923/31/2025
0.37915 % AQR Capital Management, LLC98,13798,1373/31/2025
1
2
3
4
5
...
10

AVITA Medical Executives and Management Board

Mr. James Corbett

(65)
AVITA Medical President, Chief Executive Officer, Executive Director (since 2021)
Compensation 2.07 M

Mr. David O'Toole

(65)
AVITA Medical Chief Financial Officer
Compensation 2.01 M

Mr. Robert Mcnamara

(67)
AVITA Medical Independent Non-Executive Director
Compensation 369,108

Mr. Cary Vance

(58)
AVITA Medical Independent Non-Executive Director
Compensation 364,941

Mr. Lou Panaccio

(66)
AVITA Medical Independent Non-Executive Chairman of the board (since 2014)
Compensation 234,686
1
2

AVITA Medical Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
BlackRock Stock
BlackRock
SupplierCustomer0,280,850,860,960,80-0,29
Premier A Stock
Premier A
SupplierCustomer-0,23-0,06-0,340,660,05-0,57
M3 Stock
M3
SupplierCustomer-0,540,780,570,860,940,57
1

Most common questions regarding AVITA Medical

What values and corporate philosophy does AVITA Medical represent?

AVITA Medical Inc represents a values-driven corporate philosophy focused on transforming lives through innovative medical solutions. The company prioritizes patient-centric healthcare and aims to deliver cutting-edge regenerative products and technologies. AVITA Medical Inc is dedicated to providing advancements in the field of regenerative medicine, particularly in the treatment of acute and chronic wounds. By combining science, medical expertise, and compassion, AVITA Medical Inc strives to improve patient outcomes and enhance quality of life. As a leader in regenerative medicine, AVITA Medical Inc remains committed to sustainability, ethical practices, and driving meaningful change in the healthcare industry.

In which countries and regions is AVITA Medical primarily present?

AVITA Medical Inc primarily operates in the United States, Europe, and Australia.

What significant milestones has the company AVITA Medical achieved?

AVITA Medical Inc has achieved significant milestones in its journey. One notable accomplishment includes the FDA approval of its flagship product, RECELL® System, in September 2018. This innovative regenerative medicine device is used for the treatment of acute thermal burns in patients. Additionally, AVITA Medical Inc successfully established partnerships with leading medical centers and institutions globally, facilitating the adoption and utilization of the RECELL System. The company has also significantly expanded its global presence by securing market approvals in various countries. AVITA Medical Inc continues to make advancements in regenerative medicine, revolutionizing burn treatment and positively impacting patients' lives.

What is the history and background of the company AVITA Medical?

AVITA Medical Inc. is a leading regenerative medicine company that specializes in the development and commercialization of innovative therapies for a range of skin conditions. Founded in 2002, AVITA Medical has grown into a globally recognized and respected company in the field. It is dedicated to utilizing its proprietary technology platform, the RECELL® System, to provide innovative and transformative solutions for patients with burns, chronic wounds, and aesthetic conditions. With a strong commitment to research and development, AVITA Medical continues to expand its product portfolio and improve patients' lives worldwide through its cutting-edge regenerative medicine treatments.

Who are the main competitors of AVITA Medical in the market?

The main competitors of AVITA Medical Inc in the market include companies such as Acelity (formerly known as KCI), Molnlycke Health Care, Smith & Nephew, and Dermatix.

In which industries is AVITA Medical primarily active?

AVITA Medical Inc is primarily active in the healthcare and biotechnology industries. With a focus on regenerative medicine solutions, AVITA Medical specializes in developing and commercializing innovative treatments for wounds, burns, and other skin-related conditions. Through its proprietary technology called the RECELL® System, the company aims to revolutionize the way healthcare professionals offer personalized skin regeneration solutions. AVITA Medical Inc's commitment to advancing patient care within the healthcare and biotech sectors has positioned it as a leader in the field, with its products offering promising benefits and potential advancements in wound healing and skin restoration.

What is the business model of AVITA Medical?

AVITA Medical Inc is a regenerative medicine company that specializes in developing and commercializing innovative treatments for a variety of skin defects and conditions. Their business model revolves around leveraging their proprietary technology, known as the RECELL® System, which enables the rapid and efficient regeneration of skin cells. AVITA Medical aims to transform the lives of patients by providing advanced solutions for burns, chronic wounds, and aesthetic indications. Through collaborations, research, and a patient-centered approach, AVITA Medical Inc strives to improve outcomes and quality of life for individuals in need of effective skin restoration.

What is the P/E ratio of AVITA Medical 2025?

The AVITA Medical P/E ratio is -8.16.

What is the P/S ratio of AVITA Medical 2025?

The AVITA Medical P/S ratio is 1.46.

What is the Quality Investing of AVITA Medical?

The Quality Investing for AVITA Medical is 4/10.

What is the revenue of AVITA Medical 2025?

The expected AVITA Medical revenue is 100.98 M USD.

How high is the profit of AVITA Medical 2025?

The expected AVITA Medical profit is -18.05 M USD.

What is the business model of AVITA Medical

AVITA Medical Inc is a leading company in the field of regenerative medicine, offering a wide range of products and services. The company's business model is based on three main divisions: the development and marketing of innovative and effective regenerative medicine products, the provision of wound care services, and the distribution of products and devices for medical applications. The first division of AVITA Medical's business model is the development and marketing of regenerative medicine products. The company specializes in the production of dermographs used to treat patients with severe skin injuries or defects. The company's core technology platform is the RECELL system, an automated and portable unit for producing cell therapy products from the patient's fresh tissue. Using this technology, the company can produce customized therapeutic products for a variety of applications, including burns, chronic wounds, and skin reconstruction. The second division of AVITA Medical's business model is the provision of wound care services. The company offers a wide range of services tailored to the needs of patients with severe skin injuries or defects. These services include surgical procedures, conservative wound care, and other measures to accelerate wound healing and improve skin regeneration. The third division of AVITA Medical's business model is the distribution of products and devices for medical applications. The company distributes a wide range of medical devices and accessories, including instruments for the application of the RECELL system and dermographs. In addition, customers can also access training and consulting services to ensure the proper use of the devices and products. Overall, AVITA Medical Inc is committed to improving the treatment of patients with serious skin injuries and defects, and to providing them with a better quality of life. The company has developed a wide range of products and services tailored to the needs of these patients. By utilizing the company's advanced technology platform, doctors and surgeons can produce customized therapeutic products specifically tailored to the needs of each individual patient, thereby reducing treatment duration and accelerating healing. AVITA Medical strives to continuously improve its products and services and develop new innovations to further enhance the treatment of patients with skin injuries and defects.

What is the AVITA Medical dividend?

AVITA Medical pays a dividend of 0 USD distributed over payouts per year.

How often does AVITA Medical pay dividends?

The dividend cannot currently be calculated for AVITA Medical or the company does not pay out a dividend.

What is the AVITA Medical ISIN?

The ISIN of AVITA Medical is US05380C1027.

What is the AVITA Medical WKN?

The WKN of AVITA Medical is A2P733.

What is the AVITA Medical ticker?

The ticker of AVITA Medical is RCEL.

How much dividend does AVITA Medical pay?

Over the past 12 months, AVITA Medical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, AVITA Medical is expected to pay a dividend of 0 USD.

What is the dividend yield of AVITA Medical?

The current dividend yield of AVITA Medical is .

When does AVITA Medical pay dividends?

AVITA Medical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of AVITA Medical?

AVITA Medical paid dividends every year for the past 0 years.

What is the dividend of AVITA Medical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is AVITA Medical located?

AVITA Medical is assigned to the 'Health' sector.

Wann musste ich die Aktien von AVITA Medical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of AVITA Medical from 8/16/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/16/2025.

When did AVITA Medical pay the last dividend?

The last dividend was paid out on 8/16/2025.

What was the dividend of AVITA Medical in the year 2024?

In the year 2024, AVITA Medical distributed 0 USD as dividends.

In which currency does AVITA Medical pay out the dividend?

The dividends of AVITA Medical are distributed in USD.

All fundamentals about AVITA Medical

Our stock analysis for AVITA Medical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of AVITA Medical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.